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Abstract We investigated cellular signaling and pepsinogen 
secretion in the human gastric adenocarcinoma cell line AGS 
which was pretreated with the purified vacuolating cytotoxin 
from Helicobactev pyfori. Results indicated that vacuolating 
toxin increased the levels of inositol phosphates, cytosolic free 
calcium concentration, adenosine 3’,5’-cyclic monophosphate, 
and phosphorylation of 31 kDa and 22 kDa proteins in the host 
cells. Moreover, pepsinogen secretion from AGS cells was 
stimulated with increasing concentrations of cytotoxin. We 
conclude that besides the H. pylori cytotoxin-induced cellular 
vacuoles, cytotoxin-stimulated signaling mediators and pepsino- 
gen release are important factors involved in the etiology of 
chronic active gastritis and peptic ulcer disease. 
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1. Introduction 
The vacuolating toxin (cytotoxin; CT) of Helicobacter py- 
lori has been proved to induce the formation of intracellular 
vacuoles in eukaryotic cells in vitro [l-3]. Since H. pylori 
strains isolated from patients with ulcer disease commonly 
produce CT, it has been proposed that CT may be a virulence 
factor in the pathogenesis of H. pylori-related gastric diseases 
[4-91. However, there is still no direct evidence regarding the 
virulence role of H. pylori CT on in vivo pathogenesis. In 
animal model experiments, purified CT and H. pylori whole- 
cell extracts cause a similar tissue damage and ulceration 
when administered orally to mice, suggesting that CT may 
be responsible for H. pylori-related gastric diseases [lO,l 11. 
Contrary data reported by Eaton et al. showed that there 
were no differences in the colonization rate, inflammation, 
or epithelial vacuolization in gnotobiotic piglets given CT- 
positive or -negative strains, suggesting that CT is not an 
important pathogenic factor in this animal model [12,13]. Be- 
cause the aforementioned conflicting data regarding the 
vacuolating activity of H. pylori CT on pathogenesis remain, 
further studies on CT are required to identify other pheno- 
typic characteristics than vacuolating activity, which may be 
responsible for the specific H. pylori-related diseases. 
Thus, the objective of this study is to characterize H. pylori 
CT at the effect on the transmembrane signaling pathway in 
cultured cells, and we report for the first time that purified H. 
pylori CT is able to activate major second messengers and 
increase pepsinogen secretion from human gastric adenocarci- 
noma cells (AGS). 
It has been reported that pepsinogen levels are significantly 
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increased in individuals with peptic ulcer diseases [14]. There- 
fore, the characteristics of CT to increase pepsinogen secretion 
from the host cells may be associated with the pathogenesis of 
H. pylori-related diseases. 
2. Materials and methods 
2.1. Materials 
Brucella broth, chocolate agar and hemoglobin were purchased 
form Difco Lab. (Detroit, MI). Eagle medium, RPM1 1640 medium, 
fetal calf serum (FCS), and 50-cm2 tissue culture flasks were obtained 
from Gibco Lab. (Grand Island, NY). Penicillin, streptomycin, tryp- 
sin, trypan blue, bovine serum albumin, pepsinogen, ammonium for- 
mate and isobutylmethylxanthine (IBMX) were purchased from Sig- 
ma (St. Louis, MO). HEPES. Dercholic acid. formic acid and ethvlene 
glycb-his@-a&noethylether):iJ-tetraacetii acid (EGTA) were-pur- 
chased from Merck (Darmstadt, Germany). Fura-2/AM was obtained 
from Boehringer Mannheim (Mannheim, Germany). [32P]Phosphoric 
acid and [3H]inositol were obtained from Amersham Inc. (Bucking- 
hamshire, UK). 
2.2. PuriJication of H. pylori CT 
The cytotoxin-positive H. pylori strain K8 was a gift of Chang 
Gung Memorial Hospital at Taiwan. Bacterial cells were cultured 
on chocolate agar plates at 37°C in a microaerophilic atmosphere of 
10% CO2 in air and 95% humidity for 3 days. The grown colonies 
were used as inocula and were suspended in a 500-ml flask containing 
150 ml of Brucella broth supplemented with 10% FCS and 0.2% p- 
cyclodextrin. Culture was incubated at 37°C with shaking (100 rpm) 
in a microaerobic environment by placing the flask in an anaerobic jar 
containing CampyPaks (Becton Dickinson) to generate the proper 
conditions. After 72-h incubation, the culture broth was harvested 
as the raw material for CT purification. 
Culture broth was precipitated with saturated ammonium sulfate 
and resuspended in 20 mM Tris-HCl buffer (pH 7.7). The crude pro- 
tein solution was applied to an isoelectric focusing cell (Mini-Rotofor 
Cell, Bio-Rad) and operated according to the instructions. Bio-Lyte 
(Bio-Rad) was prepared at a final concentration of 1% (v/v), and with 
a pH range of 5-8. The system was run at constant power 14 W at 
4°C. Anion exchange chromatography was performed on an Econo- 
Pat Q cartridge (Bio-Rad), and proteins were eluted with 20 mM Tris- 
HCl containing a linear gradient of 0.3-0.5 M NaCl over 20 min. 
High pressure liquid chromatography (HPLC) with a preparative 
gel filtration column Bio-Sil SEC 250-5 (Bio-Rad) was performed 
with a mobile buffer containing 60 mM Tris-HCl and 0.1 M NaCl 
at a flow rate of 1 ml/min. The eluents were monitored for UV ab- 
sorbance at 280 nm, and each collected fraction was determined for 
the vacuolating activity of CT. 
2.3. Assay of CT activity 
HeLa cells were cultured in the basal Eagle medium containing 5% 
FCS in a 96-well plate to produce a confluent monolayer after 24 h of 
incubation as described by Cover et al. [6]. The purified CT was 
serially diluted and 100 pl aliquots were incubated with adherent cells 
in 96-well plates for 18 h at 37°C. HeLa cell vacuolation was quanti- 
fied spectrophotometrically at wavelength 540 nm using a neutral red 
uptake assay [15]. The unit of CT activity was defined as the amount 
of CT that increased the optical density by 0.01 in the neutral red 
assay, and the specific activity was defined as the total CT activity per 
mg protein. 
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2.4. Determination of cytosolic free calcium concentration [Ca”]i 
Fluorescence assay with fura-2/AM as a probe was employed for 
measuring [Ca’+]i in cultured cells [16]. The confluent AGS cells 
grown in RPM1 1640 medium were harvested from tissue culture flask 
by trypsinization (0.25% trypsin). Cells were resuspended in RPM1 
1640 medium containing 4 pM fura-2/AM, and incubated at 37°C 
in 5% COs incubator for 5 min. In the studies designed to determine 
the role of [Ca’+]i in CT-induced AGS cells, a concentration of 
1.25~ lo6 cells/ml was incubated with a series of dilutions of CT in 
Krebs-Ringer buffer with 1.3 mM CaCls or without extracellular Ca2+ 
(by adding 1 mM EGTA). Fluorescence was measured by a spectro- 
fluorimeter (Jasco CAF-110). The average of [Ca2+]i was calculated as 
described by Grynkiewicz et al. [17]. 
12 3 4 M 
kDa 
2.5. Determination of intracellular CAMP levels 
AGS cells (2 x 1 O6 cells/ml) were preincubated with 10 pM IBMX in 
RPM1 1640 with 0.2% bovine serum albumin at 37°C for 2 min. The 
indicated amount of CT was then added, and the reaction mixture 
was incubated for another 30 min. The reaction was stopped in boil- 
ing water for 5 min, and the concentration of CAMP in the solution 
was determined using an enzyme-linked immunoassay kit according to 
the manufacturer’s instruction (Cayman Lab., Ann Arbor, MI). 
+22 
+--I4 
Fig. 1. _ _ SDS-PAGE (10% polyacrylamide) of H. pylori cytotoxin. 
2.6. Measurement of inositol phosphates 
Total inositol phosphates were measured according to the method 
described by Jennings et al. [18]. The cultured AGS cells were incu- 
bated with [3H]myo-inositol, washed with a Dulbecco-phosphate buf- 
fer, and resuspended in a Krebs-Ringer solution to a concentration of 
2.3~ lo6 cells/ml. Various amounts of CT were added to the cell 
solutions and incubated at 37°C for 5 min. The reaction was stopped 
by adding 3 volumes of CHCls:CHsOH:HCl (100:200:2). Inositol 
monophosphate (IPi), inositol biphosphate (IPs), and inositol triphos- 
phate (IP3) were collected off a Dowex anion exchange column (AG 
l-X8 resin, 100-200 mesh formate form) with 0.2, 0.5, and 1.0 M 
ammonium formate in 0.1 M formic acid, respectively. The amounts 
of IPi, IP2, and IPs were represented by the radioactivity (dpm), and 
their sum was the value of total inositol phosphate (IPs). 
Lane 1, proteins precipitated from a broth culture supernatant of 
CT-positive H. pylori with a 50% saturated solution of ammonium 
sulfate; lane 2, CT purified by IEF chromatography; lane 3, CT 
purified partially by cation exchanger; lane 4, a major band indicat- 
ing purified ?t4, = 87 000 toxin after gel filtration HPLC. Chromatog- 
raphy conditions were as described in the text. Lane M, a low 
molecular weight marker protein. Each lane contains 0.05 units of 
CT in the purified fraction. 
experiments. The differences between treatment groups were deter- 
mined using a random analysis of variance. The Student-Newman- 
Keuls test was used to compare the treatment means where applic- 
able. 
2.7. Pepsinogen measurement 3. Results 
AGS cells were suspended in cultured medium with a concentration 
of 2.3~ lo6 cells/ml) and preincubated at 37°C for 30 min. Various 
amounts of CT were then added and incubated for another 30 min. 
After AGS cells were centrifuged, the supernatant was used for pep- 
sinogen determination. Pepsinogen was measured by the method de- 
scribed previously [19,20] using an acid-denatured hemoglobin as the 
substrate. Porcine pepsinogen was used as a standard to quantify the 
samples’ pepsinogen. 
2.8. Phosphorylation of AGS proteins 
The harvested AGS cells were preincubated with 1 mCi 
[32P]phosphoric acid in 10 ml RPM1 1640 containing 10% FCS at 
37°C for 45 min. Cells were then washed and resuspended in 2 ml 
Krebs-Ringer solution (pH 7.2). Various amounts of CT were added 
into the cell suspensions and incubated for 5 min. The reaction was 
stopped by boiling and aliquots were subjected to SDS-polyacryl- 
amide (11%) gel electrophoresis in Laemmli buffer system [21]. Auto- 
radiograms were obtained from the dried gel after exposure to Kodak 
BioMax MR film at -70°C. The phosphorylated proteins were quan- 
tified by scanning densitometry. 
2.9. Statistical methods 
Results are expressed as means + S.E.; n indicates the number of 
H. pylori CT in culture broth was precipitated with a satu- 
rated solution of ammonium sulfate. The precipitated proteins 
were resuspended and subjected to preparative isoelectric fo- 
cusing chromatography, and CT activity was detected in the 
pH range 4.6-6.3 fractions that eluted from the column. These 
fractions were then chromatographed on an Econo-Pat Q 
anion exchange column, and CT activity was detected in a 
single peak. In the final purification step, the sample was 
subjected to HPLC preparative gel filtration, and CT activity 
was detected in the first peak. As summarized in Table 1, 
analysis of the specific activities at each stage in the purifica- 
tion process indicated that H. pylori CT was purified up to 
5800-fold from the crude culture broth. The purified CT was 
then used as a stimulus in all the following experiments. The 
purity of CT was shown by 10% SDS-PAGE (Fig. 1). After 
gel filtration chromatography, all fractions with significant CT 
activity contained a band approximately at M, = 87000. By 
heating the purified CT in a boiling water bath for 5 min, its 
Table 1 
Purification of vacuolating toxin from Helicobacter pylori 
Purification step Specific activity& Purification 
(uniupg) (-fold) 
Broth culture supernatant 0.03 1 
50% Ammonium sulfate precipitate 0.07 2 
Isoelectric focusing 0.12 4 
Econo-Pat Q chromatography 3.25 108 
Bio-Sil SEC 250-5 high performance liquid chromatography 174.92 5830 
“The unit of specific activity and chromatography conditions were as specified in the text. 
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Table 2 
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Effect of CT on the production of [3H]inositol phosphates in AGS cells’ 
CT (pg/ml)b challenge (% of control) 
13WW [3WIPz [3HlIP3 
Basal control 100.0 f 2.6 100.0 It: 3.6 100.0 f 3.8 
0.18 101.2+ 1.3 166.2 f 9.7 97.5 + 5.4 
0.36 100.6 f 2.3 178.5 + 14.2 110.6 + 6.9 
0.72 104.1 f 7.3 205.3 f 22.1 130.1 f9.8 
1.0 90.3 f 2.1 200.4 f 18.5 258.3 k26.1 
1.8 97.3 k 6.9 186.5 + 20.4 270.9 f 30.1 
“Values given are means f S.E.M. from at least 3 seaarate experiments. 
bThere aYe 175 units per ug of CT. 
cellular vacuolating effect and cellular signaling induction minor of 22 kDa, as being induced in CT-pretreated 
were completely inactivated. cells (Fig. 2). 
To examine the effect of CT on phosphoinositide metabo- 
lism, we measured the levels in cellular IP1, IP2, and IPs, the 
metabolites of inositol phospholipid hydrolysis. In the pres- 
ence of calcium, CT dose-response studies were performed, 
and the results indicated that CT induced increases in IPa 
and IPa but not IP1 (Table 2). 
In cultured AGS cells, the mean basal [Ca2+]i was 45 f 3 
nM (n = S), and addition of the purified CT induced a tran- 
sient and rapid increase in [Ca”]i. As shown in Table 3, 
[Ca’+]i was stimulated in a CT dose-dependent manner. In 
order to distinguish the source of the increased [Ca2+]i, the 
effect of CT was examined in EGTA-supplemented cell sus- 
pension. Removal of extracellular Ca2+ using EGTA reduced 
basal [Ca2+li from 45 to 22 nM but did not affect the response 
to CT. This indicates that CT-induced Ca2+ mobilization in 
AGS cells is not only dependent on extracellular Ca2+ sources 
but also on intracellular stores (Table 3). 
The ability of CT to stimulate pepsinogen secretion from 
AGS cells was examined with or without the presence of cal- 
cium. As shown in Table 4, in the presence of EGTA (without 
calcium) and in the presence of 1.3 mM calcium, CT caused 
increases in pepsinogen secretion to the same extent. It is 
evident from these data that a small amount of calcium 
(from CT-induced intracellular calcium pools) is enough to 
enhance CT-induced pepsinogen secretion. 
4. Discussion 
In cultured AGS cells, 60 l&ml CT induced a 4-fold in- 
crease in CAMP formation (Table 3), and the stimulatory 
effect of CT on CAMP formation was dose-dependent. 
In this study, we used the purified H. pylori CT to investi- 
gate its signaling effect and pepsinogen secretion on a gastric 
cell line. The high purity of CT was illustrated on SDS-PAGE 
(Fig. 1). The heat inactivation of the CT preparation abolishes 
the vacuolation and signaling effects indicating that the prep- 
aration contains a highly purified CT but not LPS or some 
cell wall materials which might interfere in the investigation. 
The results in the present study indicate that in AGS cells, 
To investigate whether phosphorylation of host cell pro- 
teins was stimulated by CT, extracts were made of 
[32P]phosphoric acid-preincubated AGS cells alone and after 
CT treatment. These extracts were separated by SDS-PAGE 
and followed by autoradiography. Phosphorylation of two 
host proteins was identified, a major one of 31 kDa and a 
kDa 
Table 3 
Effect of CT on [Ca*‘]i and [CAMP] in AGS cells 
45- 
31- 
CT @g/ml) challenge CaCla [Ca’+]i [CAMP] 
(nM) (pmol/106 cells) 
Control + 45f3 10.2+0.3 
5 + 60f9 10.7fO.l 
10 + 79f2 12.0 f 0.6 
20 + 110+ 10 13.5+ 1.1 
40 + 2Olk 23 25.5 f 1.3 
60 + 289 f 29 38.3 f 1.8 
Control _ 22f4 
5 _ 38f5 
10 _ 65f9 
20 _ 89+18 
40 _ 156229 
60 _ 182221 
For [Ca’+]i measurements the AGS cells were stimulated with CT in 
the presence or in the absence of extracellular Ca’+. The rise in 
[Ca’+]i was evaluated as described in the text. Data represent the 
mean f S.E.M. of 5 different experiments. 
22- 
IS- 
Fig. 2. The phosphorylation of proteins in AGS cells stimulated by 
CT. The AGS cells with [32P]phosphoric acid were preincubated for 
1 min at 37°C then the various amounts of CT (lanes 14: 2, 5, 
10, and 20 &ml; lane C: control) were added for another 5 min. 
Proteins were separated by a 11% SDS-PAGE. 
AGS 
130 
Table 4 
Effect of CT preincubation on pepsinogen secretion from AGS cells 
CT challenge Pepsinogen secretion 
(&ml) &g/lo6 cells) 
-EGTA +EGTA 
Control 1.50 f 0.04 1.44+0.05 
10 3.15f0.06 3.18 f0.06 
20 8.25 f 0.34 8.11 f0.12 
50 11.25f0.68 10.89 f 0.85 
70 15.39 f 0.36 14.58 f 0.65 
Values given are means * S.E.M. from at least 3 separate experiments. 
AGS cells were preincubated with various amounts of CT with or 
without 1.5 mM extracellular Ca2+ (adding 1 .O mM EGTA to deprive 
extracellular Ca’+). 
H. pylori CT acts as a classical first messenger to activate the 
two signaling pathways that are currently thought to mediate 
agonist-induced pepsinogen secretion [22]. One pathway is 
mediated by CT-activated phospholipase and a consequent 
increase in IPs. It has been reported that increased IPs can 
stimulate [Ca2+]i released from intracellular stores [23]. There- 
fore, we suggest that H. pylori CT can be classified as agents 
like cholecystokinin, carbachol, and gastrin which are re- 
ported to interact with cell membrane receptors to activate 
IPs production and a consequent increase in [Ca’+]i [23-251. 
The other pathway is mediated by CT-activated adenylcyclase 
and a consequent increase in cellular level of CAMP. There- 
fore, H. pylori CT has similar characteristics to agents like 
secretin, vasoactive intestinal peptide, prostaglandins, and 
cholera toxin which can interact with the cell membrane to 
increase the cellular level of CAMP [22,26,27]. 
Increases in both cellular levels of CAMP and calcium result 
in activation of protein kinases and/or phosphatases, and con- 
sequently mediate the final steps that result in pepsinogen 
secretion through a currently unknown mechanism [22]. Pep- 
sinogen is known to be increased in serum of duodenal ulcer 
patients [14]. In the present study, we observed that CT in- 
duces phosphorylation of host proteins and pepsinogen secre- 
tion from AGS. Further work is required to identify the 
phosphated proteins and to determine their mechanism in 
mediating pepsinogen secretion in AGS cells. 
In conclusion, we have demonstrate that H. pylori CT is 
able to activate transmembrane signals in host cells, such as 
increases in the levels of IPs, [Ca2+]i, CAMP, and protein 
phosphorylation, and consequently stimulates pepsinogen se- 
cretion. In the presence of gastric acid, pepsinogen is con- 
verted to an active proteolytic enzyme, pepsin. We propose 
that increased luminal pepsin activity resulting from elevated 
H. pylori CT concentration could degrade the gastric mucus 
layer, which might enable gastric acid to injure the underlying 
epithelium and consequently to form chronic active gastritis 
and peptic ulcers. 
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